Stay updated on Zimura for AMD: Phase 3 Clinical Trial
Sign up to get notified when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.

Latest updates to the Zimura for AMD: Phase 3 Clinical Trial page
- Check3 days agoChange DetectedThe completed Phase 3 study record for avacincaptad pegol in geographic atrophy is displayed, with study details, eligibility criteria, outcome measures, participating locations, publications, and related documents. Previously, the page showed a 403 Forbidden error.SummaryDifference100%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide NIH notice about a terminology transition appears above the 403 error page. The study record itself remains inaccessible.SummaryDifference1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden error page with the HTML boilerplate and a 403 message, replacing the previous content. A Home button is visible on the error screen.SummaryDifference17%

Stay in the know with updates to Zimura for AMD: Phase 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.